Результаты поиска - Helen J. Lachmann

Отмена результатов
  1. 1
    Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease

    Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease по Ashutosh D. Wechalekar, Helen J. Lachmann, Mark Offer, Philip N. Hawkins, Julian D. Gillmore

    Опубликовано 2008-02-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  2. 2
    Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosis

    Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of c... по Ashutosh D. Wechalekar, Julian D. Gillmore, Nancy Wassef, Helen J. Lachmann, Carol Whelan, Philip N. Hawkins

    Опубликовано 2011-07-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  3. 3
    A Retrospective Patient Chart Review and Survey in Patients with Cryopyrin-associated Periodic Syndromes Treated with Anakinra

    A Retrospective Patient Chart Review and Survey in Patients with Cryopyrin-associated Periodic Syndromes Treated with Anakinra по Helen J. Lachmann, Renée J.G. Arnold, Marco Gattorno, Isabelle Koné-Paut, Alberto Ferreira, Jasmin Kümmerle-Deschner

    Опубликовано 2013-08-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  4. 4
    Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndrome

    Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associ... по Abdulkadir A. Elmi, Karen Wynne, Iek L. Cheng, Despina Eleftheriou, Helen J. Lachmann, Philip N. Hawkins, Paul Brogan

    Опубликовано 2019-07-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  5. 5
    Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center

    Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral... по Claire J. Peet, Dorota Rowczenio, Ebun Omoyinmi, Charalampia Papadopoulou, Bella Ruth R. Mapalo, Michael R. Wood, Francesca Capon, Helen J. Lachmann

    Опубликовано 2022-06-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  6. 6
    Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis

    Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis по Sajitha Sachchithanantham, Mark Offer, Christopher Venner, Shameem A. Mahmood, Darren Foard, Lisa Rannigan, Thirusha Lane, Julian D. Gillmore, Helen J. Lachmann, Philip N. Hawkins, Ashutosh D. Wechalekar

    Опубликовано 2015-11-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  7. 7
    A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial

    A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial по Suzie Cro, Prakash Patel, Jonathan Barker, David A. Burden, Christopher E. M. Griffiths, Helen J. Lachmann, Nick J. Reynolds, Richard B. Warren, Francesca Capon, Catherine Smith, Victoria Cornelius

    Опубликовано 2020-02-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  8. 8
    Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate

    Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate по Jack A. Bibby, Harriet A. Purvis, Thomas Hayday, Anita Chandra, Klaus Okkenhaug, Sofia Rosenzweig, Ivona Aksentijevich, Michael Wood, Helen J. Lachmann, Claudia Kemper, Andrew P. Cope, Esperanza Perucha

    Опубликовано 2020-07-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  9. 9
    Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria

    Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria по Faye A. Sharpley, Marianna Fontana, Ana Martinez-Naharro, Richa Manwani, Shameem Mahmood, Sajitha Sachchithanantham, Helen J. Lachmann, Julian D. Gillmore, Carol J. Whelan, Philip N. Hawkins, Ashutosh D. Wechalekar

    Опубликовано 2020-05-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  10. 10
    The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey

    The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey по Jerold Jeyaratnam, Nienke M. ter Haar, Helen J. Lachmann, Ozgur Kasapcopur, Amanda K. Ombrello, Donato Rigante, Fatma Dedeoglu, Ezgi H. Baris, Sebastiaan J. Vastert, Nico M. Wulffraat, Joost Frenkel

    Опубликовано 2018-03-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  11. 11
    Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis

    Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis по Richa Manwani, Darren Foard, Shameem Mahmood, Sajitha Sachchithanantham, Thirusha Lane, Cristina Quarta, Taryn Youngstein, Tamer Rezk, Helen J Lachmann, Julian D. Gillmore, Marianna Fontana, Carol Whelan, Philip N. Hawkins, Ashutosh Wechalekar

    Опубликовано 2018-04-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  12. 12
    Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib

    Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib по Sriram Ravichandran, Oliver C. Cohen, Steven Law, Darren Foard, Marianna Fontana, Ana Martinez-Naharro, Carol Whelan, Julian D. Gillmore, Helen J. Lachmann, Sajitha Sachchithanantham, Shameem Mahmood, Philip N. Hawkins, Ashutosh D. Wechalekar

    Опубликовано 2021-06-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  13. 13
    Limited utility of Mayo 2012 cardiac staging system for risk stratification of patients with advanced cardiac AL amyloidosis - analysis of a uniformly treated cohort of 1,275 patients

    Limited utility of Mayo 2012 cardiac staging system for risk stratification of patients with advanced cardiac AL amyloidosis - analysis of a uniformly treated cohort of 1,275 patie... по Jahanzaib Khwaja, Sriram Ravichandran, Joshua Bomsztyk, Oliver Cohen, Darren Foard, Ana Martinez-Naharro, Lucia Venneri, Marianna Fontana, Philip N. Hawkins, Julian Gillmore, Helen J. Lachmann, Shameem Mahmood, Carol Whelan, Amy A. Kirkwood, Ashutosh Wechalekar

    Опубликовано 2024-01-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  14. 14
    The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis

    The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis по Tamer Rezk, Janet A Gilbertson, P Patrizia Mangione, Dorota Rowczenio, Nigel B Rendell, Diana Canetti, Helen J Lachmann, Ashutosh D Wechalekar, Paul Bass, Philip N Hawkins, Vittorio Bellotti, Graham W Taylor, Julian D Gillmore

    Опубликовано 2019-07-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  15. 15
    A prospective study of nutritional status in immunoglobulin light chain amyloidosis

    A prospective study of nutritional status in immunoglobulin light chain amyloidosis по Prayman T. Sattianayagam, Thirusha Lane, Zoe Fox, Aviva Petrie, Simon D.J. Gibbs, Jennifer H. Pinney, Signe S. Risom, Dorota M. Rowczenio, Ashutosh D. Wechalekar, Helen J. Lachmann, Janet A. Gilbertson, Philip N. Hawkins, Julian D. Gillmore

    Опубликовано 2013-01-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  16. 16
    Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting

    Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting по Christopher P. Venner, Julian D. Gillmore, Sajitha Sachchithanantham, Shameem Mahmood, Thirusha Lane, Darren Foard, Murielle Roussel, Lisa Rannigan, Simon DJ Gibbs, Jennifer H Pinney, Carol J. Whelan, Helen J. Lachmann, Philip N. Hawkins, Ashutosh D. Wechalekar

    Опубликовано 2014-12-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  17. 17
    Late-Onset Cryopyrin-Associated Periodic Syndromes Caused by Somatic NLRP3 Mosaicism—UK Single Center Experience

    Late-Onset Cryopyrin-Associated Periodic Syndromes Caused by Somatic NLRP3 Mosaicism—UK Single Center Experience по Dorota M. Rowczenio, Sónia Melo Gomes, Juan I. Aróstegui, Anna Mensa-Vilaro, Ebun Omoyinmi, Hadija Trojer, Anna Baginska, Alberto Baroja-Mazo, Pablo Pelegrin, Sinisa Savic, Thirusha Lane, Rene Williams, Paul Brogan, Helen J. Lachmann, Philip N. Hawkins

    Опубликовано 2017-10-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  18. 18
    Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage

    Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage по Steven Law, Aviva Petrie, Liza Chacko, Oliver C. Cohen, Sriram Ravichandran, Janet A. Gilbertson, Dorota Rowczenio, Ashutosh Wechalekar, Ana Martinez‐Naharro, Helen J. Lachmann, Carol J. Whelan, David F. Hutt, Philip N. Hawkins, Marianna Fontana, Julian D. Gillmore

    Опубликовано 2020-12-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  19. 19
    Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis.

    Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis. по Ebun Omoyinmi, Ariane Standing, Annette Keylock, Fiona Price-Kuehne, Sonia Melo Gomes, Dorota Rowczenio, Sira Nanthapisal, Thomas Cullup, Rodney Nyanhete, Emma Ashton, Claire Murphy, Megan Clarke, Helena Ahlfors, Lucy Jenkins, Kimberly Gilmour, Despina Eleftheriou, Helen J Lachmann, Philip N Hawkins, Nigel Klein, Paul A Brogan

    Опубликовано 2017-01-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:
  20. 20
    Complement receptor CD46 co-stimulates optimal human CD8+ T cell effector function via fatty acid metabolism

    Complement receptor CD46 co-stimulates optimal human CD8+ T cell effector function via fatty acid metabolism по Giuseppina Arbore, Erin E. West, Jubayer Rahman, Gaelle Le Friec, Nathalie Niyonzima, Mehdi Pirooznia, Ilker Tunc, Polychronis Pavlidis, Nicholas Powell, Yuesheng Li, Poching Liu, Aude Servais, Lionel Couzi, Veronique Fremeaux-Bacchi, Leo Placais, Alastair Ferraro, Patrick R. Walsh, David Kavanagh, Behdad Afzali, Paul Lavender, Helen J. Lachmann, Claudia Kemper

    Опубликовано 2018-10-01
    Полный текст
    Статья
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: